The epidemiology of cervical cancer

被引:187
作者
Franco, EL
Schlecht, NF
Saslow, D
机构
[1] McGill Univ, Div Canc Epidemiol, Dept Epidemiol, Montreal, PQ H2W 1S6, Canada
[2] McGill Univ, Dept Oncol, Montreal, PQ, Canada
[3] Albert Einstein Coll Med, Dept Epidemiol & Populat Health, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA
[5] Amer Canc Soc, Dept Canc Control Sci, Atlanta, GA 30329 USA
关键词
cervical neoplasms; screening; prevention; epidemiology; Pap test; human papillomavirus; CIN;
D O I
10.1097/00130404-200309000-00004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical cancer is one of the most common neoplastic diseases affecting women, with a combined worldwide incidence of almost half a million new cases annually, second only to breast cancer. Basic and epidemiologic research conducted during the past 15-20 years have provided overwhelming evidence for an etiologic role for infection with certain types of sexually-transmitted human papillomavirus (HPV) as the primary cause of cervical cancer. The relative risks of cervical cancer following HPV infection as ascertained in case-control and cohort studies are among the highest in cancer epidemiology. The available evidence indicates that the HPV-cervical cancer association satisfies all relevant causal criteria for public health action. Other cervical cancer risk factors, such as smoking, parity, use of oral contraceptives, diet, other infections, and host susceptibility traits must be understood in the context of mediation of acquisition of HPV infection or in influencing events of the natural history of cervical neoplasia that occur following the establishment of a persistent HPV infection. Virtually all cervical carcinoma specimens contain HPV DNA, which suggests that HPV infection is a necessary cause of cervical neoplasia. This is the first instance in which a necessary cause has been demonstrated in cancer epidemiology-a realization that has obvious implications for primary and secondary prevention of this neoplastic disease.
引用
收藏
页码:348 / 359
页数:12
相关论文
共 175 条
  • [1] [Anonymous], 1992, MMWR Recomm Rep, V41, P1
  • [2] [Anonymous], 2003, CANC FACTS FIG
  • [3] [Anonymous], 1996, Cancer Epidemiology and Prevention
  • [4] Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
    Anttila, T
    Saikku, P
    Koskela, P
    Bloigu, A
    Dillner, J
    Ikäheimo, I
    Jellum, E
    Lehtinen, M
    Lenner, P
    Hakulinen, T
    Närvänen, A
    Pukkala, E
    Thoresen, S
    Youngman, L
    Paavonen, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (01): : 47 - 51
  • [5] COMPARISON OF HUMAN-LEUKOCYTE ANTIGEN DR-DQ DISEASE ASSOCIATIONS FOUND WITH CERVICAL DYSPLASIA AND INVASIVE CERVICAL-CARCINOMA
    APPLE, RJ
    BECKER, TM
    WHEELER, CM
    ERLICH, HA
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (06): : 427 - 436
  • [6] HLA DR-DQ ASSOCIATIONS WITH CERVICAL-CARCINOMA SHOW PAPILLOMAVIRUS-TYPE SPECIFICITY
    APPLE, RJ
    ERLICH, HA
    KLITZ, W
    MANOS, MM
    BECKER, TM
    WHEELER, CM
    [J]. NATURE GENETICS, 1994, 6 (02) : 157 - 162
  • [7] Asian-American variants of human papillomavirus 16 and risk for cervical cancer:: a case-control study
    Berumen, J
    Ordoñez, RM
    Lazcano, E
    Salmeron, J
    Galvan, SC
    Estrada, RA
    Yunes, E
    Garcia-Carranca, A
    Madrigal-de la Campa, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (17): : 1325 - 1330
  • [8] Bontkes HJ, 1998, INT J CANCER, V78, P166, DOI 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO
  • [9] 2-X
  • [10] BOSCH FX, 1993, CANCER EPIDEM BIOMAR, V2, P415